Challenges in the Early Diagnosis, Screening and Management of Heart Failure in Patients with Chronic Obstructive Pulmonary Disease
Open Access
- 14 April 2026
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 2978
Abstract
In patients with co-morbid CHF and COPD, the diagnosis of CHF can be delayed. It is also well known that left ventricular dysfunction can arise from progressive disease-related hyperinflation. Apart from the longitudinal risk of developing CHF in some patients, a short-term or subclinical risk of cardiac events has been reported after hospitalization for COPD exacerbation. Currently there are no data or strategies to support screening for the early diagnosis of CHF in patients with COPD. Similarly, pulmonary function testing results can also be confounding and inaccurate in establishing the severity of COPD during an active exacerbation of CHF. The hyperinflation of the lungs, which can alter LV geometry and mechanics, is at the root of many of the causes of LV underfilling, which eventually contributes to CHF. Conventional echocardiography can often miss subclinical myocardial dysfunction and hence make early diagnosis even more challenging. Advanced cardiac imaging modalities and revised echocardiographic parameters can help detect subclinical LV dysfunction and PH earlier, but there are no clinical outcome data to validate their routine use in day-to-day clinical practice. Beta-blockers are generally regarded as safe to be used for appropriate cardiovascular indications in patients with COPD, and recent trials have also established the safety of long-acting beta agonists for treating COPD in patients with elevated cardiac risk.Keywords
This publication has 99 references indexed in Scilit:
- Phenotyping Patients with Chronic Obstructive Pulmonary Disease and Heart FailureESC Heart Failure, 2024
- Association of COPD with Adverse Outcomes in Heart Failure Patients with Preserved Ejection FractionESC Heart Failure, 2024
- Chronic non-invasive ventilation for chronic obstructive pulmonary diseaseCochrane Database of Systematic Reviews, 2021
- Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA‐HFEuropean Journal of Heart Failure, 2020
- Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary DiseaseJAMA, 2019
- Misclassification of Both Chronic Obstructive Pulmonary Disease and Heart FailureJAMA Network Open, 2018
- Relationship Between Heart Failure, Concurrent Chronic Obstructive Pulmonary Disease and Beta-Blocker Use: A Danish Nationwide Cohort StudyEuropean Journal of Heart Failure, 2017
- Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary diseaseCochrane Database of Systematic Reviews, 2017
- Lung Congestion in Chronic Heart Failure: Haemodynamic, Clinical, and Prognostic ImplicationsEuropean Journal of Heart Failure, 2015
- Chronic Obstructive Pulmonary Disease in Heart Failure: Accurate Diagnosis and TreatmentEuropean Journal of Heart Failure, 2014